Incidence of Internal Cancers and Ingested Inorganic Arsenic: A Seven-Year Follow-up Study in Taiwan

Cancer Research

Volumn 55, Issue 6, 1995, Pages 1296-1300

  Chiou, Hung Yi ^a,b   Hsueh, Yu Mei ^a,b   Liaw, Kuen Fu ^a   Horng, Shan Far ^a   Chiang, Ming Hsi ^a   Pu, Yeong Shiau ^c   Lin, Johnny Shinn Nan ^d   Huang, Chun Hsiung ^e   Chen, Chien Jen ^a,f  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^f INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; WELL WATER;

ARTICLE; BLACKFOOT DISEASE; BLADDER CANCER; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; WATER CONTAMINATION;

ARSENIC; BLADDER NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMAN; INCIDENCE; LUNG NEOPLASMS; MALE; NEOPLASMS; PERIPHERAL VASCULAR DISEASES; SUPPORT, NON-U.S. GOV'T; TAIWAN; TIME FACTORS; WATER POLLUTANTS, CHEMICAL;

EID: 0028919048     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. WHO. Environmental Health Criteria 18:Arsenic. Geneva:WHO, 1981.
2. USPHS. Toxicological Profile for Arsenic. Washington, DC:USPHS, 1989.
3. Smith, A. H., Hopehayn-Rich C., Bates, M. N., Goeden, H. M., Hertz-Picciotto I., Duggan, H. M., Wood, R., et al. Cancer risks from arsenic in drinking water. Environ. Health Perspect., 97:259–267, 1992.
4. Tseng, W. P. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ. Health Perspect., 19:109–119, 1968.
5. Chen, C. J., Wu, M. M., Lee, S. S., Wang, J. D., Cheng, S. H., and Wu, H. Y. Atherogenicity and carcinogenicity of high-arsenic artesian well water:multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis, 8:452–460, 1980.
6. Tseng, W. P., Chen, W. Y., Sung, J. L., and Chen, J. S. A clinical study of blackfoot disease in Taiwan:an endemic peripheral vascular disease. Mem. Coll. Med. Natl. Taiwan Univ., 7:1–18, 1961.
7. Yeh, S., and How, S. W. A pathological study on the blackfoot disease in Taiwan. Report Inst. Pathol. Natl. Taiwan Univ., 14:25–73, 1963.
8. Feldstein, A. L. Arsenic and respiratory cancer in man:follow-up of copper smelter employees in Montana. J. Natl. Cancer Inst., 70:601–609, 1983.
9. Feldstein, A. L. Cumulative exposure to arsenic and its relationship to respiratory cancer among copper smelter employees. J. Occup. Med., 28:296–302, 1986.
10. Feldstein, A. LA comparison of several measures of exposure to arsenic:matched case-control study of copper smelter employees. Am. J. Epidemiol., 103:226–235, 1989.
11. Enterline, P. E., and Marsh, G. M. Mortality studies of smelter worker. Am. J. Ind. Med., 7:251–259, 1980.
12. Enterline, P. E., and Marsh, G. M. Mortality among workers exposed to arsenic and other substances in a copper smelter. Am. J. Epidemiol., 116:895–910, 1982.
13. Enterline, P. E., Henderson, V. L., and Marsh, G. M. Exposure to arsenic and respiratory cancer. Am. J. Epidemiol., 125:929–938, 1987.
14. Goldman, A. L. Lung cancer in Bowen's disease. Am. Rev. Respir. Dis., 108:1205–1207, 1973.
15. Luchtrath, H. The consequences of chronic arsenic poisoning among Moselle wine growers:pathoanatorn ical investigations of post-mortem examinations performed between 1960 and 1977. J. Cancer Res. Clin. Oncol., 105:173–182, 1983.
16. Chen, C. J., Chuang, Y. C., Lin, T. M., and Wu, H. Y. Malignant neoplasms among residents of a blackfoot disease endemic area in Taiwan:high arsenic artesian well water and cancers. Cancer Res., 45:5895–5899, 1985.
17. Chen, C. J., Chuang, Y. C., You, S. L., and Wu, H. Y. A retrospective study on malignant neoplasms of bladder, lung, and liver in blackfoot disease endemic area in Taiwan. Br. J. Cancer, 53:399–405, 1986.
18. Chen, C. J., Wu, M. M., and Kuo, T. L., Arsenic and cancers. Lancet, 1:414–415, 1988.
19. Chen, C. J., and Wang, C. J. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res., 50:5470–5474, 1990.
20. Chen, C. J., Chen, C. W., Wu, M. M., and Kuo, T. T. Cancer potential in liver, lung, bladder, and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer, 66:888–892, 1992.
21. Wu, M. M., Kuo, T. L., Hwang, Y. H., and Chen, C. J. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am. J. Epidemiol., 130:1123–1131, 1989.
22. Kasper, M. L., Schoenfield, L., Strom, R. L., and Theologides, A. Hepatic angiosarcoma and bronchioloalveolar carcinoma induced by Fowler's solution. JAMA, 252:3407–3408, 1984.
23. Falk, H., Herbert, J. T., and Edmonds, L. Review of four cases of childhood hepatic angiosarcoma:elevated environmental arsenic exposure in one case. Cancer (Phila.), 47:383–391, 1981.
24. International Agency for Research on Cancer. Evaluation of Carcinogenic Risks to Humans (Suppl. 7), pp. 100–106. Lyon, France:International Agency for Research on Cancer, 1987.
25. Cuzick, J., Sasieni, P., and Evan S. Ingested arsenic, keratosis, and bladder cancer. Am. J. Epidemiol., 136:417–421, 1992.
26. Wu, H. Y., Chen, K. P., Tseng, W. P., and Hsu, C. L. Epidemiologic studies on blackfoot disease. 1. Prevalence and incidence of the disease by age, sex, year, occupation, and geographic distribution. In:Mem. Coll. Med. Natl. Taiwan Univ., 7:33–50, 1961.
27. Chen, K. P., Wu, H. Y., and Wu, T. C. Epidemiologic studies on blackfoot disease in Taiwan. 3. Physicochemical characteristics of drinking water in endemic blackfoot disease area. In:Mem. Coll. Med., Natl. Taiwan Univ., 8:115–129, 1962.
28. Blackwell, R. Q. Estimation total arsenic ingested by residents in the endemic blackfoot area. J. Formosan Med. Assoc., 60:1143–1144, 1961.
29. Lai, M. S., Hsueh, Y. M., Chen, C. J., Shyu, M. P., Chen, S. Y., Kuo, T. L., Wu, M. M., et al. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am. J. Epidemiol., 139:1–9, 1994.
30. Kuo, T. L. Arsenic content of artesian well water in endemic area of chronic arsenic poisoning. Report. Inst. Pathol. Natl. Taiwan Univ. 20:7–13, 1964.
31. Cox, D. R. Regression models and life tables. J. R. Stat Soc., 34:187–220, 1972.
32. Breslow, N. E., and Day, N. E. Statistical Methods in Cancer Research, Vol. 2, pp. 120–176. Lyon:International Agency for Research on Cancer, 1987.
33. Yen, S. J., and Yang, M. H. Trace elements in water samples from endemic area of blackfoot disease and biospecimens from blackfoot disease patients:a preliminary report. Blackfoot Dis. Res. Rep., 8:22–28, 1980.
34. Lu, F. J. Blackfoot disease:arsenic or humic acid? Lancet, 2:115–116, 1990.
35. Chen, C. J. Blackfoot disease. Lancet, 2:442, 1990.
36. Gerhard S. Arsenic:opportunity for risk assessment. Arch. Toxicol., 65:525–531, 1991.
37. Brown, C. C., and Chu, K. C. A new method for the analysis of cohort studies:implication of the multistage theory of carcinogenesis applied to occupational arsenic exposure. Environ. Health Perspect., 50:293–308, 1983.
38. Chu, K. Biomathematical models for cancer:A nonmathematical view of mathematical models for cancer. J. Chronic Dis., 40 (Suppl. 2):163–170, 1987.
39. Lee, T. C., Oshimura, M., and Barrett, J. C. Comparison of arsenic-induced cell transformation, cytotoxicity mutation and cytogenetic effects in Syrian hamster embryo cells in culture. Carcinogenesis (Lond.), 6:1421–1426, 1985.
40. Burgdorf, W., Kurrink, K., and Cerrenka, J. Elevated sister chromatid exchange rate in lymphocytes of subjects treated with arsenic. Hum. Genet., 36:69–72, 1977.
41. Lee, T. C., Tanaka, N., Lamb, P. W., et al. Induction of gene amplification by arsenic. Science (Washington DC), 241:79–81, 1988.
42. David, J. K., and Montalbano, D. The reproductive effects assessment groups report on the mutagenicity of inorganic arsenic. Environ. Mutagen., 7:787–804, 1985.